证券记录 · 已归档季度
GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
22被追踪持有人
-1Δ持有人
560.26M持有股份
$62.11B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 -4.3% ·
股份流向 +2.0% ·
净新建仓位 -4.5%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | +1 | 941.63M | $119.04B | +5 | −3 |
| Q1 2026 | 176 | +4 | 930.86M | $129.53B | +6 | −3 |
| Q4 2025 | 171 | 0 | 1.00B | $122.89B | +1 | — |
| Q3 2025 | 23 | -1 | 603.99M | $67.03B | — | −2 |
| Q2 2025 | 22 | -1 | 560.26M | $62.11B | — | −1 |
| Q1 2025 | 20 | 0 | 255.31M | $28.60B | — | — |
| Q4 2024 | 20 | +1 | 270.33M | $24.97B | +1 | — |
| Q3 2024 | 18 | 0 | 213.42M | $17.89B | — | — |
| Q2 2024 | 18 | — | 202.41M | $13.88B | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 119.36M | — | $13.23B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 114.88M | — | $12.74B | 0.2% | n/c | 1 | SEC ↗ ×24 |
| 3 | Fidelity (FMR) ✦ | 59.96M | — | $6.65B | 0.4% | n/c | 1 | SEC ↗ ×8 |
| 4 | State Street Global Advisors ✦ (被动) | 59.19M | -0.6% | $6.56B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 5 | Capital World Investors ✦ | 46.30M | -13.5% | $5.13B | 0.7% | ▼ Trim | 5 | SEC ↗ |
| 6 | Wellington Management ✦ | 37.53M | +37.2% | $4.16B | 0.8% | ▲ Add | 5 | SEC ↗ ×9 |
| 7 | Dodge & Cox ✦ | 30.82M | -5.7% | $3.42B | 1.9% | ▼ Trim | 5 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 29.21M | +2.5% | $3.23B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 23.59M | +60.4% | $2.62B | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | Norges Bank ✦ (被动) | 19.39M | -2.3% | $2.15B | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 5.67M | +4.0% | $628.23M | 0.8% | ▲ Add | 5 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 5.47M | +1.8% | $606.52M | 0.5% | ▲ Add | 5 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 2.47M | +32.5% | $272.21M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 14 | Marshall Wace ✦ | 1.95M | +152.1% | $216.29M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | Adage Capital Partners ✦ | 1.45M | +10.1% | $161.12M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 764.15K | -69.9% | $84.72M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 700.23K | +54.3% | $77.63M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 18 | Bridgewater Associates ✦ | 666.30K | +32.5% | $73.87M | 0.3% | ▲ Add | 5 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 426.58K | +690.1% | $47.30M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 282.20K | +12.4% | $31.29M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 164.73K | -67.8% | $18.26M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | Fisher Asset Management ✦ | 10.70K | +54.0% | $1.19M | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Two Sigma Investments | $4.86M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 61.30K 股份, $8,543 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 15
Mercier Johanna
Officer · 1.60K 股 · $229,907
Sep 15
Mercier Johanna
Officer · 600 股 · $87,174
Sep 15
Mercier Johanna
Officer · 800 股 · $115,566
Sep 15
Dickinson Andrew D
Officer · 3.00K 股 · $435,870
Sep 01
O'Day Daniel Patrick
Officer, Director · 7.99K 股 · $1.19M
Sep 01
O'Day Daniel Patrick
Officer, Director · 1.60K 股 · $236,014
Sep 01
O'Day Daniel Patrick
Officer, Director · 5.41K 股 · $807,856
Aug 26
WELTERS ANTHONY
Director · 3.40K 股 · $504,296
Aug 26
WELTERS ANTHONY
Director · 3.12K 股 · $462,432
Aug 26
WELTERS ANTHONY
Director · 4.60K 股 · $684,590
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据